Table 5.
Effect Of E-OA-07 And Placebo On EQ-5D-5L Scores
| Domains | Visit | Placebo (n=23) | E-OA-07 (n=21) | p value* | ||||
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | 95% CI | Mean (SD) | 95% CI | |||||
| Min | Max | Min | Max | |||||
| Mobility | Day 0 | 3.09 (0.67) | 2.80 | 3.38 | 3.24 (0.70) | 2.92 | 3.56 | 0.324 |
| Day 56 | 3.52 (0.99) | 3.09 | 3.95 | 1.67 (0.73) | 1.33 | 2.00 | <0.001 | |
| p** | 0.008 | <0.001 | ||||||
| Self-care | Day 0 | 2.65 (1.03) | 2.21 | 3.10 | 2.91 (0.77) | 2.56 | 3.26 | 0.408 |
| Day 56 | 2.96 (0.88) | 2.58 | 3.34 | 1.62 (0.81) | 1.25 | 1.99 | <0.001 | |
| p** | 0.117 | <0.001 | ||||||
| Daily Activities | Day 0 | 3.48 (0.90) | 3.09 | 3.87 | 3.48 (0.99) | 3.03 | 3.92 | 0.786 |
| Day 56 | 3.39 (1.03) | 2.95 | 3.84 | 1.86 (0.66) | 1.56 | 2.16 | <0.001 | |
| p** | 0.691 | <0.001 | ||||||
| Pain/Discomfort | Day 0 | 3.35 (0.71) | 3.04 | 3.66 | 3.67 (0.97) | 3.23 | 4.11 | 0.213 |
| Day 56 | 3.48 (1.04) | 3.03 | 3.93 | 1.81 (0.75) | 1.47 | 2.15 | <0.001 | |
| p** | 0.490 | <0.001 | ||||||
| Anxiety/Depression | Day 0 | 2.35 (1.07) | 1.89 | 2.81 | 2.57 (0.87) | 2.18 | 2.97 | 0.459 |
| Day 56 | 2.61 (0.78) | 2.27 | 2.95 | 1.62 (0.74) | 1.28 | 1.96 | <0.001 | |
| p** | 0.238 | 0.001 | ||||||
| Total | Day 0 | 14.91 (2.92) | 13.7 | 16.2 | 15.86 (2.69) | 14.63 | 17.08 | 0.265 |
| Day 56 | 15.96 (3.72) | 14.3 | 17.6 | 8.57 (3.14) | 7.14 | 10.00 | <0.001 | |
| p** | 0.141 | <0.001 | ||||||
Notes: *P, Mann–Whitney U-test; **Wilcoxon signed rank test.
Abbreviation: n, number of participants; SD, standard deviation; CI, confidence interval; Min, minimum; Max, maximum.